<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>News Article and Medical Journal &#187; Onkology Journal</title>
	<atom:link href="http://d02now.com/tag/onkology-journal/feed/" rel="self" type="application/rss+xml" />
	<link>http://d02now.com</link>
	<description></description>
	<lastBuildDate>Tue, 07 Dec 2010 17:40:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>The Pathophysiology and Therapy of Multiple Myeloma</title>
		<link>http://d02now.com/onkology/blood/stem-cells-blood-onkology/the-pathophysiology-and-therapy-of-multiple-myeloma.html</link>
		<comments>http://d02now.com/onkology/blood/stem-cells-blood-onkology/the-pathophysiology-and-therapy-of-multiple-myeloma.html#comments</comments>
		<pubDate>Wed, 24 Jun 2009 10:39:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Stem Cells]]></category>
		<category><![CDATA[autologous infusion]]></category>
		<category><![CDATA[MGUS]]></category>
		<category><![CDATA[monoclonal]]></category>
		<category><![CDATA[Myeloma]]></category>
		<category><![CDATA[Onkology Journal]]></category>
		<category><![CDATA[pathophysiology]]></category>
		<category><![CDATA[Stem Cell therapy]]></category>

		<guid isPermaLink="false">http://d02now.com/onkology/blood/stem-cells-blood-onkology/the-pathophysiology-and-therapy-of-multiple-myeloma.html</guid>
		<description><![CDATA[Multiple myeloma is a type of cancerous growth plasma cells - component of white blood cells which produces antibody in the bone marrow. Below we provide you with article about the pathophysiology and therapy of multiple myeloma.]]></description>
		<wfw:commentRss>http://d02now.com/onkology/blood/stem-cells-blood-onkology/the-pathophysiology-and-therapy-of-multiple-myeloma.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Inducing tumor-specific T-cell Responses in Patients with Metastatic Renal Cell Carcinoma</title>
		<link>http://d02now.com/onkology/inducing-tumor-specific-t-cell-responses-in-patients-with-metastatic-renal-cell-carcinoma.html</link>
		<comments>http://d02now.com/onkology/inducing-tumor-specific-t-cell-responses-in-patients-with-metastatic-renal-cell-carcinoma.html#comments</comments>
		<pubDate>Tue, 24 Mar 2009 02:42:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Onkology]]></category>
		<category><![CDATA[Ren]]></category>
		<category><![CDATA[Onkology Journal]]></category>

		<guid isPermaLink="false">http://d02now.com/2009/03/24/inducing-tumor-specific-t-cell-responses-in-patients-with-metastatic-renal-cell-carcinoma/</guid>
		<description><![CDATA[The researcher then tried to induce tumor-specific T-cell responses in subjects with metastatic renal cell carcinoma and evaluated the feasibility, safety, and its efficacy.]]></description>
		<wfw:commentRss>http://d02now.com/onkology/inducing-tumor-specific-t-cell-responses-in-patients-with-metastatic-renal-cell-carcinoma.html/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

